Blue Blends board meet Aug 14, 2026 for Q1 FY27 results
Blue Blends (India) Ltd
BLUEBLENDS
Ask Iris
Board meeting scheduled for August 14, 2026
Blue Blends (India) Ltd has scheduled a meeting of its Board of Directors for Friday, August 14, 2026. The company said the primary agenda is to consider, approve, and take on record its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, which corresponds to Q1 FY27. Such board meetings are a routine compliance milestone for listed companies, but they also act as a key date for investors tracking quarterly execution and profitability. For Blue Blends, the meeting comes after a period in which quarterly income and costs have swung sharply across recent quarters.
What the board will consider in Q1 FY27
As stated in the agenda, the board will focus on the company’s unaudited financial results for Q1 FY27 at both standalone and consolidated levels. The wording indicates three actions: considering the results, approving them, and taking them on record. This typically implies the financial statements will be formally adopted for disclosure and regulatory filing after board approval. The meeting is expected to close out the reporting cycle for the quarter ended June 30, 2026.
Company snapshot: listing and sector
Blue Blends (India) Ltd is listed on Indian stock exchanges and trades under NSE: BLUEBLENDS and BSE: 502761. The company operates in the Consumer Discretionary sector, within the Textiles and Apparels industry. The registered office address shared is JBF House, 2nd Floor, Old P. Office Lane, Kalbadevi Road, Mumbai, Maharashtra 400002.
Recent quarterly trend: income and expenses moved sharply
The company’s reported quarterly line items show a sharp change in scale between mid-FY26 and late-FY26. Total income for March 2026 was ₹74.67 crore, compared with ₹72.33 crore in December 2025 and ₹5.29 crore in September 2025. For earlier comparable points, total income is shown at ₹0.96 crore in June 2025 and ₹1.27 crore in March 2025.
On costs, total expenses for March 2026 were ₹75.18 crore, versus ₹71.91 crore in December 2025 and ₹4.87 crore in September 2025. The same table shows total expenses at ₹2.59 crore in June 2025 and ₹2.37 crore in March 2025. With expenses marginally above income in March 2026, operating profitability remained under pressure.
Operating profitability and margins: losses returned in March 2026
For March 2026, the company reported EBIT of -₹0.51 crore and PAT of -₹0.64 crore. In December 2025, EBIT and PAT were both ₹0.42 crore, while in September 2025 EBIT and PAT were also shown as ₹0.42 crore. Earlier quarters in the same table indicate losses in June 2025 (EBIT and PAT -₹1.63 crore) and March 2025 (EBIT and PAT -₹1.10 crore).
Margins also reflect the volatility. EBIT margin for March 2026 is shown at -0.68%, with net profit margin at -0.85%. December 2025 shows 0.58% for both EBIT and net profit margin, while September 2025 shows margins near 7.9%. Basic EPS is shown at -0.29 for March 2026, versus 0.19 in December 2025 and 0.19 in September 2025.
Selected financial snapshot (as provided)
All figures are in ₹ crore unless stated otherwise.
FY26 and quarterly performance references in the data
The provided information includes multiple performance references for FY26 and recent quarters. One line states the company reported a consolidated net loss of ₹14.29 crore for FY26 on revenue of ₹1,531.50 crore. Separately, another set of figures states that for the year ended March 2026, net loss was ₹1.43 crore on sales of ₹153.15 crore, compared with a net loss of ₹0.74 crore on sales of ₹5.26 crore in the year ended March 2025.
For the quarter ended March 2026, the same dataset notes a net loss of ₹0.64 crore, compared with a net loss of ₹1.10 crore during the previous quarter ended March 2025, while sales rose to ₹74.55 crore from ₹1.07 crore.
Converting the “lakhs” disclosures into ₹ crore for comparability
Some quarterly disclosures are reported in ₹ lakhs. Converting these into ₹ crore (1 crore = 100 lakhs) helps align them with the rest of the data.
The dataset also cites Q2 FY26 revenue of ₹5.2936 crore (₹529.36 lakhs) with net profit of ₹0.4166 crore (₹41.66 lakhs), and a half-year revenue of ₹6.2575 crore (₹625.75 lakhs) with net loss of ₹1.2130 crore (₹121.3 lakhs).
Why the August 14 board meeting matters for investors
For investors, the Q1 FY27 results can help confirm whether the higher revenue base seen in recent reported quarters is sustaining into the June 2026 quarter, and whether costs are stabilising relative to income. Recent quarterly data shows that even with strong topline numbers in late FY26, margins can remain tight or slip into losses when expenses rise alongside revenue. The meeting is also relevant because the agenda covers both standalone and consolidated numbers, which can differ due to subsidiary performance and consolidation adjustments.
Key date to track
The event is straightforward: the board meets on August 14, 2026 to approve unaudited Q1 FY27 results for the quarter ended June 30, 2026. Investors tracking Blue Blends will watch for the published financial statements after the meeting, which will provide the official Q1 FY27 snapshot across revenue, expenses, profitability, and EPS.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
